Three Seasons Wealth, LLC Summit Therapeutics Inc. Transaction History
Three Seasons Wealth, LLC
- $205 Billion
- Q4 2024
A detailed history of Three Seasons Wealth, LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Three Seasons Wealth, LLC holds 12,869 shares of SMMT stock, worth $277,970. This represents 0.11% of its overall portfolio holdings.
Number of Shares
12,869Holding current value
$277,970% of portfolio
0.11%Shares
1 transactions
Others Institutions Holding SMMT
# of Institutions
231Shares Held
83.1MCall Options Held
1.66MPut Options Held
2.56M-
Baker Bros. Advisors LP New York, NY24.4MShares$528 Million4.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$252 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$171 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$142 Million0.01% of portfolio
-
State Street Corp Boston, MA5.6MShares$121 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.35B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...